These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17103338)

  • 1. Pharmacokinetics and disposition of memantine in the arterially perfused bovine eye.
    Koeberle MJ; Hughes PM; Skellern GG; Wilson CG
    Pharm Res; 2006 Dec; 23(12):2781-98. PubMed ID: 17103338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bovine arterially-perfused eye: an in vitro method for the study of drug mechanisms on IOP, aqueous humour formation and uveal vasculature.
    Wilson WS; Shahidullah M; Millar C
    Curr Eye Res; 1993 Jul; 12(7):609-20. PubMed ID: 7693396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
    Amrite AC; Edelhauser HF; Singh SR; Kompella UB
    Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model.
    Abarca EM; Salmon JH; Gilger BC
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):715-22. PubMed ID: 23822159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres.
    Millar JC; Wilson WS; Carr RD; Humphries RG
    J Ocul Pharmacol Ther; 1995; 11(1):11-23. PubMed ID: 8535953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of timolol, terbutaline and forskolin on IOP, aqueous humour formation and ciliary cyclic AMP levels in the bovine eye.
    Shahidullah M; Wilson WS; Millar C
    Curr Eye Res; 1995 Jul; 14(7):519-28. PubMed ID: 7587297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior chamber perfusion versus posterior chamber perfusion does not influence measurement of aqueous outflow facility in living mice by constant flow infusion.
    Lopez NN; Patel GC; Raychaudhuri U; Aryal S; Phan TN; Clark AF; Millar JC
    Exp Eye Res; 2017 Nov; 164():95-108. PubMed ID: 28822760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
    Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
    J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gantrez AN nanoparticles for ocular delivery of memantine: in vitro release evaluation in albino rabbits.
    Prieto E; Puente B; Uixera A; Garcia de Jalon JA; Perez S; Pablo L; Irache JM; Garcia MA; Bregante MA
    Ophthalmic Res; 2012; 48(3):109-17. PubMed ID: 22538548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
    Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.
    Bisht R; Mandal A; Rupenthal ID; Mitra AK
    Drug Deliv Transl Res; 2016 Dec; 6(6):763-770. PubMed ID: 27371395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal and ciliary body blood flow analysis: application of laser Doppler flowmetry in experimental animals.
    Gherezghiher T; Okubo H; Koss MC
    Exp Eye Res; 1991 Aug; 53(2):151-6. PubMed ID: 1915670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of eye pigmentation on transscleral drug delivery.
    Cheruvu NP; Amrite AC; Kompella UB
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.
    Bernstein PS; Khachik F; Carvalho LS; Muir GJ; Zhao DY; Katz NB
    Exp Eye Res; 2001 Mar; 72(3):215-23. PubMed ID: 11180970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection.
    Nan K; Sun S; Li Y; Qu J; Li G; Luo L; Chen H; Cheng L
    Br J Ophthalmol; 2010 May; 94(5):654-8. PubMed ID: 20447969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.